GlaxoSmithKline HPV vaccine (580299)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GlaxoSmithKline HPV vaccine (580299), covering 2010-08-25 to 2010-08-25. Get the full timeline:
Most recent: Clinical Trial Update: Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age [Phase 3]